The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6
Open accessAbstract
This study investigates the molecular mechanisms underlying the induction of and protection from T cell activation-associated hepatic injury. When BALB/c mice were given a single intravenous injection of concanavalin A (Con A) (> or = 0.3 mg/mouse), they developed acute hepatic injury as assessed by a striking increase in plasma transaminase levels within 24 h. Histopathologically, only the liver was injured while moderate infiltration of T cells and polymorphonuclear cells occurred in the portal areas and around the central veins. The induction of hepatic injury was dependent on the existence as well as the activation of T cells, as untreated BALB/c nu/nu mice or BALB/c mice pretreated with a T cell-specific immunosuppressive drug, FK506, failed to develop disease. Significant increases in the levels of various cytokines in the plasma were detected before an increase in plasma transaminase levels. Within 1 h after Con A injection, tumor necrosis factor (TNF) levels peaked, this being followed by production of two other inflammatory cytokines, interleukin 6 (IL-6) and IL-1. Passive immunization with anti-TNF but not with anti-IL-1 or anti-IL-6 antibody, conferred significant levels of protection. Moreover, administration of rIL-6 before Con A injection resulted in an IL-6 dose-dependent protection. A single administration of a given dose of rIL-6 completely inhibited the release of transaminases, whereas the same regimen induced only 40-50% inhibition of TNF production. More than 80% inhibition of TNF production required four consecutive rIL-6 injections. These results indicate that: (a) TNFs are critical cytokines for inducing T cell activation-associated (Con A-induced) hepatitis; (b) the induction of hepatitis is almost completely controlled by rIL-6; and (c) rIL-6 exerts its protective effect through multiple mechanisms including the reduction of TNF production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Earlier studies demonstrated that IL-6 attenuated liver injury in Con A-induced hepatitis (1).”
From The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury (2005) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Increasing evidence demonstrates that IL-6 has a protective role during liver injury.”
From The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury (2005) · cites this paper as [1]
In the citing paper
“Moreover, it was shown that IL‐6‐deficient knockout mice have elevated levels of TNF‐α (214).”
From Muscle–Organ Crosstalk: The Emerging Roles of Myokines (2020) · cites this paper as [214]
In the citing paper
“and levels of TNF-α are markedly elevated in anti-IL-6-treated mice and in IL-6-deficient knockout mice [67, 68], indicating that circulating IL-6 is involved in the regulation of TNF-α levels.”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., & Abrams, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4185 · Cited by 322
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448 · cited 9×
“D-galactosamine, which impairs protein biosynthesis only in the liver (11), sensitizes the liver by several orders of magnitude toward subtoxic amounts of LPS (6).”
InfluentialTRANSAMINASE ACTIVITY IN HUMAN BLOOD
Karmen, A., Wröblewski, F., & LaDue, J. S. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103055 · Cited by 1,715
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B., & Cerami, A. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003205 · Cited by 1,690
Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Waage, A., Brandtzaeg, P., Halstensen, A. I., Kierulf, P., & Espevik, T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.333 · Cited by 1,175
ENDOTOXINS AND DISEASE MECHANISMS
Morrison, D. C., & Ryan, J. L. (1987) · Annual Review of Medicine · doi:10.1146/annurev.me.38.020187.002221 · Cited by 1,111
A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs, G., Hentschel, J., & Wendel, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115836 · Cited by 1,077
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 515
CTLA-4 regulates cell cycle progression during a primary immune response
Greenwald, R. J., Oosterwegel, M. A., van der Woude, D., Kubal, A., Mandelbrot, D. A., Boussiotis, V. A., & Sharpe, A. H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2 · Cited by 120
CCR5 Deficiency Exacerbates T-Cell–Mediated Hepatitis in Mice *
Moreno, C., Gustot, T., Nicaise, C., Quertinmont, E., Nagy, N., Parmentier, M., Moine, O. L., Deviere, J. M., & Louis, H. (2005) · Hepatology · doi:10.1002/hep.20865 · Cited by 100
Nakashima, H., Kinoshita, M., Nakashima, M., Habu, Y., Shono, S., Uchida, T., Shinomiya, N., & Seki, S. (2008) · Hepatology · doi:10.1002/hep.22561 · Cited by 99
Li, J., Xia, Y., Liu, T., Wang, J., Dai, W., Wang, F., Zheng, Y., Chen, K., Li, S., Abudumijiti, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120440 · Cited by 98
Bustos, M., Beraza, N., Lasarte, J.-J., Baixeras, E., Alzuguren, P., Bordet, T., & Prieto, J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00698-x · Cited by 97
Chen, D., McKallip, R. J., Zeytun, A., Do, Y., Lombard, C. A., Robertson, J. L., Mak, T. W., Nagarkatti, P. S., & Nagarkatti, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5889 · Cited by 97
Raisins and additional walking have distinct effects on plasma lipids and inflammatory cytokines
Puglisi, M. J., Vaishnav, U., Shrestha, S., Torres‐Gonzalez, M., Wood, R. J., Volek, J. S., & Fernández, M. L. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-14 · Cited by 101
Concanavalin A Induces Perforin–Mediated But Not Fas–Mediated Hepatic Injury
Watanabe, Y., Morita, M., & Akaike, T. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008781346 · Cited by 97
Chuang, H., Lay, J., Hsieh, W., & Su, I. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00549.x · Cited by 95
Funk, J. A., Gohlke, J. M., Kraft, A. D., McPherson, C. A., Collins, J. B., & Harry, G. J. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.012 · Cited by 95
Siegrist, C., Barrios, C. S., Martínez, X., Brandt, C., Berney, M., Córdova, M., Kovařík, J., & Lambert, P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12 · Cited by 184
Neuroprotective Effects of Exercise Treatments after Injury: The Dual Role of Neurotrophic Factors
Cobianchi, S., Arbat-Plana, A., Lopez-Alvarez, V. M., & Navarro, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160330105132 · Cited by 94
Bulau, A., Fink, M., Maucksch, C., Kappler, R., Mayr, D. C., Wagner, K., & Bufler, P. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/968479 · Cited by 93
Gantner, F., Leist, M., Jilg, S., Germann, P., Freudenberg, M. A., & Tiegs, G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90282-1 · Cited by 92
Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus
Malaguarnera, M., Fazio, I. D., Romeo, M. A., Restuccia, S., Laurino, A., & Trovato, B. A. (1997) · Journal of Gastroenterology · doi:10.1007/bf02936370 · Cited by 91
Fiorucci, S., Mencarelli, A., Palazzetti, B., Soldato, P. D., Morelli, A., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041603898 · Cited by 91
Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism
Wang, J., Sun, R., Wei, H., Dong, Z., Gao, B., & Tian, Z. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.015 · Cited by 89
Gorham, J. D., Lin, J. T., Sung, J. L., Rudner, L. A., & French, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6413 · Cited by 89
Bourdi, M., Eiras, D., Holt, M. P., Webster, M. R., Reilly, T., Welch, K., & Pohl, L. (2007) · Chemical Research in Toxicology · doi:10.1021/tx060228l · Cited by 80
Metsios, G. S., Stavropoulos‐Kalinoglou, A., Sandoo, A., Zanten, J. V., Toms, T. E., John, H., & Kitas, G. D. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004020089 · Cited by 90
Concanavalin A-induced liver injury triggers hepatocyte proliferation.
Trautwein, C., Rakemann, T., Malek, N. P., Plümpe, J., Tiegs, G., & Manns, M. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci504 · Cited by 87
Saito, T., Okumura, A., Watanabe, H., Asano, M., Ishida‐Okawara, A., Sakagami, J., Sudo, K., Hatano-Yokoe, Y., Bezbradica, J. S., Joyce, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.579 · Cited by 86
Wang, H., & Li, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.080 · Cited by 86
Tilg, H. (2001) · Canadian Journal of Gastroenterology · doi:10.1155/2001/746736 · Cited by 84
Khan, H. A., Ahmad, M. Z., Khan, J. A., & Arshad, M. I. (2017) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(17)60014-6 · Cited by 87
Ajuebor, M. N., Wondimu, Z., Hogaboam, C. M., Le, T. P., Proudfoot, A. E. I., & Swain, M. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060690 · Cited by 82
Ajuebor, M. N., Aspinall, A. I., Zhou, F. L., Le, T. P., Yang, Y., Urbanski, S. J., Sidobre, S., Kronenberg, M., Hogaboam, C. M., & Swain, M. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.8027 · Cited by 84
Immunoregulatory Effector Cells in Drug-Induced Toxic Epidermal Necrolysis
Paquet, P., Paquet, F., Saleh, W. A., Reper, P., Vanderkelen, A., & Pierard, G. (2000) · American Journal of Dermatopathology · doi:10.1097/00000372-200010000-00005 · Cited by 83
Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration
Drucker, C., Gewiese, J., Malchow, S., Scheller, J., & Rose-John, S. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.003 · Cited by 83
Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice
Zhou, Y., Dai, W., Lin, C., Wang, F., He, L., Shen, M., Chen, P., Wang, C., Lu, J., Xu, L., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/706156 · Cited by 82
Nicoletti, F., Marco, R. D., Zaccone, P., Salvaggio, A., Magro, G. G., Bendtzen, K., & Meroni, P. L. (2000) · Hepatology · doi:10.1053/jhep.2000.17701 · Cited by 81
Zhang, S., Liang, R., Luo, W., Liu, C., Wu, X., Gao, Y., Hao, J., Cao, G., Chen, X., Wei, J., et al. (2012) · Hepatology · doi:10.1002/hep.26166 · Cited by 80
Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C
Larrea, E., García, N., Qian, C., Civeira, M. P., & Prìeto, J. (1996) · Hepatology · doi:10.1002/hep.510230203 · Cited by 80
RIPK1 protects from TNF-α-mediated liver damage during hepatitis
Filliol, A. A., Piquet‐Pellorce, C., Seyec, J. L., Farooq, M., Genêt, V., Lucas‐Clerc, C., Bertin, J., Gough, P. J., Dimanche‐Boitrel, M., Vandenabeele, P., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.362 · Cited by 81
Effects of ovotransferrin on chicken macrophages and heterophil-granulocytes
Xie, H., Huff, G. R., HUFF, W. E., BALOG, J. M., & Rath, N. C. (2002) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(02)00028-9 · Cited by 79
Fengler, V. H., Macheiner, T., Kessler, S. M., Czepukojc, B., Gemperlein, K., Müller, R., Kiemer, A. K., Magnes, C., Haybaeck, J., Lackner, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155163 · Cited by 78
Bang, R., Sass, G., Kiemer, A. K., Vollmar, A. M., Neuhuber, W., & Tiegs, G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043539 · Cited by 78
Interleukin-11 reduces T-cell-dependent experimental liver injury in mice
Bozza, M., Bliss, J. L., Maylor, R., Erickson, J., Donnelly, L. H., Bouchard, P. R., Dorner, A. J., & Trepicchio, W. L. (1999) · Hepatology · doi:10.1002/hep.510300616 · Cited by 77
Ajuebor, M. N., Hogaboam, C. M., Le, T. P., Proudfoot, A. E. I., & Swain, M. G. (2004) · European Journal of Immunology · doi:10.1002/eji.200425071 · Cited by 75
Bruck, R., Aeed, H., Brazovsky, E., Noor, T., & Hershkoviz, R. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01050.x · Cited by 76
Liu, Y., Li, F., Zhang, L., Wu, J., Wang, Y., & Yu, H. H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7414 · Cited by 73
Miyagi, T., Takehara, T., Tatsumi, T., Suzuki, T., Jinushi, M., Kanazawa, Y., Hiramatsu, N., Kanto, T., Tsuji, S., Hori, M., et al. (2004) · Hepatology · doi:10.1002/hep.20447 · Cited by 73
Castellani, P., Angelini, G., Delfino, L., Matucci, A., & Rubartelli, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200838439 · Cited by 71
Role of monocytes and macrophages in experimental and human acute liver failure
Possamai, L. A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i15.1811 · Cited by 74
Meador, B. M., Krzyszton, C. P., Johnson, R. W., & Huey, K. A. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01079.2007 · Cited by 72
Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins
Schümann, J., & Tiegs, G. (1999) · Toxicology · doi:10.1016/s0300-483x(99)00087-6 · Cited by 72
Smith, M. C., Cohen, D. N., Greig, B. W., Yenamandra, A. K., Vnencak‐Jones, C. L., Thompson, M. A., & Kim, A. S. (2014) · PubMed Central · Cited by 71
Zeng, T., Deng, G., Zhong, W., Gao, Z., Ma, S., Mo, C., Li, Y., Huang, S., Zhou, C., Lai, Y., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.009 · Cited by 71
Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury
Ryu, K., Kim, S.-Y., Kim, Y.-R., Woo, S., Sung, S. H., Kim, H. S., Jung, S., Jo, I., & Park, J. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.06.007 · Cited by 70
Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity
Gupta, G., Khadem, F., & Uzonna, J. E. (2018) · Cytokine · doi:10.1016/j.cyto.2018.09.004 · Cited by 72
Ajuebor, M. N., Hogaboam, C. M., Le, T. P., & Swain, M. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5252 · Cited by 69
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes
Margalit, M., Ghazala, S. A., Alper, R., Elinav, E., Klein, A., Doviner, V., Sherman, Y., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00105.2005 · Cited by 69
Critical role of interleukin 5 and eosinophils in concanavalin A–induced hepatitis in mice
Louis, H., Moine, A. L., Flamand, V., Nagy, N., Quertinmont, E., Paulart, F., Abramowicz, D., Moine, O. L., Goldman, M., & Deviere, J. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33620 · Cited by 69
Hentze, H., Gantner, F., Kolb, S., & Wendel, A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65076-6 · Cited by 69
Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection
Ortega‐Prieto, A. M., & Dorner, M. (2017) · Vaccines · doi:10.3390/vaccines5030024 · Cited by 68
Miyazawa, Y., Tsutsui, H., Mizuhara, H., Fujiwara, H., & Kaneda, K. (1998) · Hepatology · doi:10.1002/hep.510270225 · Cited by 68
Protection from T Cell-Mediated Murine Liver Failure by Phosphodiesterase Inhibitors
Gantner, F., Küsters, S., Wendel, A., Hatzelmann, A., Schudt, C., & Tiegs, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36389-x · Cited by 67
Cao, Q., Batey, R. G., Pang, G., Russell, A., & Clancy, R. L. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00779.x · Cited by 67
Meier, R. P. H., Meyer, J., Montanari, E., Lacotte, S., Balaphas, A., Müller, Y. D., Clément, S., Negro, F., Toso, C., Morel, P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061295 · Cited by 66
Rakemann, T., Niehof, M., Kubicka, S., Fischer, M., Manns, M. P., Rose‐John, S., & Trautwein, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1257 · Cited by 66
Interleukin-6 Augments Neutrophil Cytotoxic Potential via Selective Enhancement of Elastase Release
Johnson, J. L., Moore, E. E., Tamura, D. Y., Zallen, G. S., Biffl, W. L., & Silliman, C. C. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5295 · Cited by 66
LIVER-INFILTRATING T LYMPHOCYTES ARE ATTRACTED SELECTIVELY BY IFN-INDUCIBLE PROTEIN-10
Tamaru, M., Nishioji, K., Kobayashi, Y., Watanabe, Y., Itoh, Y., Okanoue, T., Murai, M., Matsushima, K., & Narumi, S. (2000) · Cytokine · doi:10.1006/cyto.1999.0560 · Cited by 65
IFN-γ Promotes Fas Ligand- and Perforin-Mediated Liver Cell Destruction by Cytotoxic CD8 T Cells
Roth, E., & Pircher, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1588 · Cited by 64
Ognjanovic, S., Yuan, J.-M., Chaptman, A. K., Fan, Y.-H., & Yu, M.-M. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgn286 · Cited by 66
A Key Pathogenic Role for the Stat1/T–Bet Signaling Pathway in T–Cell-Mediated Liver Inflammation
Siebler, J., Wirtz, S. J., Klein, S., Protschka, M., Blessing, M., Galle, P. R., & Neurath, M. F. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.020 · Cited by 62
Thirunavukkarasu, C., Uemura, T., Wang, L. F., Watkins, S. C., & Gandhi, C. R. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20366 · Cited by 61
Marco, R. D., Xiang, M., Zaccone, P., Leonardi, C., Franco, S., Meroni, P. L., & Nicoletti, F. (1999) · Autoimmunity · doi:10.3109/08916939908994050 · Cited by 62
Li, B., Sun, R., Wei, H., Gao, B., & Tian, Z. (2006) · Hepatology · doi:10.1002/hep.21174 · Cited by 62
McMillian, M., Nie, A. Y., Parker, J. B., Leone, A. M., Kemmerer, M., Bryant, S., Herlich, J., Yieh, L., Bittner, A., Liu, X., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.01.029 · Cited by 62
A novel mechanism of murine hepatocyte death inducible by Concanavalin A
Leist, M., & Wendel, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80301-1 · Cited by 62
The Effect of Aging on Circulating Levels of Proinflammatory Cytokines During Septic Shock
Marik, P. E., Zaloga, G. P., & and the Norasept II Study Investigators (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49003.x · Cited by 58
Choukèr, A., Thiel, M., Lukashev, D. E., Ward, J. M., Kaufmann, I., Apasov, S. G., Sitkovsky, M. V., & Ohta, A. (2008) · Molecular Medicine · doi:10.2119/2007-00075.chouker · Cited by 59
Iron deficiency impairs Intra-hepatic lymphocyte mediated immune response
Bonaccorsi-Riani, E., Danger, R., Lozano, J. J., Martinez-Picola, M., Kodela, E., Mas-Malavila, R., Bruguera, M., Collins, H. L., Hider, R. C., Martinez-Llordella, M., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136106 · Cited by 57
Such, J. M., Hillebrand, D. J., Guarner, C., Berk, L., Zapater, P., Westengard, J., Peralta, C., Soriano, G., Pappas, J. M., & Runyon, B. A. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1012342929326 · Cited by 57
Cytokine Responses at High Altitude
Hagobian, T. A., Jacobs, K. A., Subudhi, A. W., Fattor, J. A., Rock, P. B., Muza, S. R., Fulco, C. S., Braun, B., Grediagin, A., Mazzeo, R. S., et al. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000188577.63910.51 · Cited by 56
Streetz, K. L., Fregien, B., Plümpe, J., Koerber, K., Kubicka, S., Sass, G., Bischoff, S. C., Manns, M. P., Tiegs, G., & Trautwein, C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.514 · Cited by 55
Cheng, L., Wang, J., Li, X., Xing, Q. R., Du, P., Su, L., & Wang, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017631 · Cited by 55
Tu, C., Han, B., Liu, H., & Zhang, S. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0920-4 · Cited by 55
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models
Shibata, H., Yoshioka, Y., Ohkawa, A., Abe, Y., Nomura, T., Mukai, Y., Nakagawa, S., Taniai, M., Ohta, T., Mayumi, T., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.003 · Cited by 55
Louis, H., Moine, A. L., Quertinmont, E., Peny, M.-O., Geerts, A. E., Goldman, M., Moine, O. L., & Deviere, J. M. E. (2000) · Hepatology · doi:10.1002/hep.510310218 · Cited by 55
Shimizu, H., Matsuguchi, T., Fukuda, Y., Nakano, I., Hayakawa, T., Takeuchi, O., Akira, S., Umemura, M., Suda, T., & Yoshikai, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.36006 · Cited by 53
Nakamura, K., Okada, M., Yoneda, M., Takamoto, S., Nakade, Y., Tamori, K., Aso, K., & Makino, I. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00109-x · Cited by 54
Yin, H., Cheng, L., Langenbach, R. J., & Ju, C. (2006) · Hepatology · doi:10.1002/hep.21493 · Cited by 54
Wang, J., Zhao, Y., & Xu, Q. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023033 · Cited by 54
Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice
Liu, D., Zhang, X., Jiang, L., Guo, Y., & Zheng, C.-Q. (2014) · Acta Histochemica · doi:10.1016/j.acthis.2013.12.002 · Cited by 53
Yang, P., Zhou, W., Li, C., Zhang, M., Jiang, Y., Jiang, R., Ba, H., Li, C., Wang, J., Yin, B., et al. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2252-2 · Cited by 51
Ballerstädt, R., Evans, C., Gowda, A., & McNichols, R. J. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.296 · Cited by 52
Sañudo, B., Seixas, A., Gloeckl, R., Rittweger, J., Rawer, R., Taïar, R., van der Zee, E. A., van Heuvelen, M. J. G., Lacerda, A. C. R., Sartório, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103650 · Cited by 53
Zhao, Y. X., Liu, J., Wang, J., Wang, L., Yin, H., Tan, R. X., & Xu, Q. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023592 · Cited by 52
High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice
Gong, Q., Zhang, H., Li, J., Duan, L., Zhong, S., Kong, X., Zheng, F., Tan, Z., Xiong, P., Chen, G., et al. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0681-7 · Cited by 51
Kimura, K., Ando, K., Ohnishi, H., Ishikawa, T., Kakumu, S., Takemura, M., Muto, Y., & Moriwaki, H. (1999) · International Immunology · doi:10.1093/intimm/11.9.1491 · Cited by 51
Mizuhara, H., Kuno, M., Seki, N., Yu, W., Yamaoka, M., Yamashita, M., Ogawa, T., Kaneda, K., Fujii, T., Senoh, H., et al. (1998) · Hepatology · doi:10.1002/hep.510270227 · Cited by 51
Costelli, P., Aoki, M. P., Zingaro, B., Carbó, N., Reffo, P., López-Soriano, F. J., Bonelli, G., Argilés, J. M. A., & Baccino, F. M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401281 · Cited by 48
Feng, C., Wang, H., Yao, C., Zhang, J., & Tian, Z. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.011 · Cited by 50
Takehara, T., Hayashi, N., Mita, E., Kanto, T., Tatsumi, T., Sasaki, Y., Kasahara, A., & Hori, M. (1998) · Hepatology · doi:10.1002/hep.510270625 · Cited by 50
Fucoidan prevents concanavalin A-induced liver injury through induction of endogenous IL-10 in mice
Saito, A., Yoneda, M., Yokohama, S., OKADA, M., Haneda, M., & Nakamura, K. (2006) · Hepatology Research · doi:10.1016/j.hepres.2006.03.012 · Cited by 49
Ravikumar, S., Gnanadesigan, M., Inbaneson, S. J., & Kalaiarasi, A. (2011) · PubMed · Cited by 49
Bimodal role of endogenous interleukin‐6 in concanavalin A‐induced hepatitis in mice
Tagawa, Y., Matthys, P., Heremans, H., Dillen, C., Zaman, Z., Iwakura, Y., & Billiau, A. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.90 · Cited by 56
Takano, M., Nishimura, H., Kimura, Y., Washizu, J., Mokuno, Y., Nimura, Y., & Yoshikai, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3019 · Cited by 49
Tiegs, G., Bang, R., & Neuhuber, W. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00014-4 · Cited by 49
Metadata
- Authors
- Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H.
- Affiliations
- New Drug Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-05-01
- Volume
- 179
- Issue
- 5
- Pages
- 1529-1537
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2191474
- OpenAlex
- W2131520834
- Cited by
- 517
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 9 · 2022: 8 · 2021: 9 · 2020: 13 · 2019: 8 · 2018: 17 · 2017: 18 · 2016: 20 · 2015: 18 · 2014: 15 · 2013: 15 · 2012: 21
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- concanavalin A-induced hepatitis, TNF-α, interleukin-6, interleukin-1, cytokines, liver injury, transaminases, T cell depletion, FK506, liver inflammation
- MeSH terms
- Animals, Antibodies, Concanavalin A, Female, Hepatitis, Animal, Humans, Immunohistochemistry, Liver, Lymphocyte Activation, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Interleukin-6, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
